Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.10 | 33.74 |
| PEG Ratio (TTM) | 0.37 | 10.35 |
| P/S Ratio (TTM) | 0.24 | 4.51 |
| P/B Ratio (TTM) | 1.24 | 6.42 |
| P/FCF Ratio (TTM) | 19.40 | 28.98 |
| Price to 5YR AVG Earnings Ratio | 65.85 | 46.91 |
| Price to 5YR AVG FCF Ratio | -51.00 | 52.45 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.31% | 8.61% |
| ROE (TTM) | 6.36% | 20.83% |
| Net Profit Margin (TTM) | 1.09% | 11.94% |
| ROIC 5YR AVG | 5.33% | 21.14% |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.93% | -189.67% | -91.48% |
| Revenue | 0.41% | -3.78% | 0.73% |
| Net Income | 16.27% | -194.03% | -93.96% |
| Cash Flow | 754.70% | -45.82% | 38.19% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.42 | 1.61 |
| Quick Ratio (TTM) | 1.22 | 1.08 |
| D/E Ratio (TTM) | 2.32 | 0.69 |
| Interest Coverage (TTM) | 3.95 | 16.59 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 2.28 | 5.34 |
| LTL to 5YR AVG FCF | -79.60 | 7.11 |
| Shares Outstanding Growth 5YR AVG | -0.33% | 0.65% |